APO Research
Talk to an analyst

APO RESEARCH · REPORT

POC Diagnostics

Point-of-care Diagnostics (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Point-of-care Diagnostics (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.

Selected research

Market Outlook & Growth Opportunities

Global POC Diagnostics Market Outlook and Growth Opportunities 2026

21 December 2025201 pages

Choose your research edition.

Industry ResearchPOC Diagnostics Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal POC Diagnostics Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal POC Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal POC Diagnostics Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal POC Diagnostics Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

Point-of-care Diagnostics (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.

In United States, POC Diagnostics key players include Alere, Roche, Abbott Laboratories, Johnson & Johnson, etc. Global top four manufacturers hold a share over 50%.

In terms of product, Blood Glucose Testing is the largest segment, with a share over 45%. And in terms of application, the largest application is Clinics, followed by Hospitals, Laboratory, etc.

Read the full market overview

This report provides an overview of the global POC Diagnostics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of POC Diagnostics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents POC Diagnostics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the POC Diagnostics market size, projected growth trends, production technologies, key applications, and end-use industries.

POC Diagnostics Segment by Company

Alere

Roche

Abbott Laboratories

Johnson & Johnson

Siemens Healthcare

Danaher

Bayer Healthcare

Beckman Coulter

Nipro Diagnostics

Bio-Rad Laboratories

Nova Biomedical

BioMerieux

Quidel

Helena Laboratories

OraSure Technologies

Accriva

Abaxis

Chembio Diagnostics

Trinity Biotech

POC Diagnostics Segment by Type

Blood Glucose Testing

Infectious Diseases Testing

Cardiac Markers Testing

Coagulation Testing

Pregnancy and Fertility Testing

Blood Gas or Electrolytes Testing

Tumor Markers Testing

Urinalysis Testing

Cholesterol Testing

Others

POC Diagnostics Segment by Application

Clinics

Hospitals

Laboratory

Others

POC Diagnostics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global POC Diagnostics status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions POC Diagnostics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify POC Diagnostics significant trends, drivers, influence factors in global and regions.

6. To analyze POC Diagnostics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global POC Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of POC Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of POC Diagnostics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the POC Diagnostics market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global POC Diagnostics industry.

Chapter 3: Detailed analysis of POC Diagnostics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of POC Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of POC Diagnostics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. POC Diagnostics Industry Trends Table 2. POC Diagnostics Industry Drivers Table 3. POC Diagnostics Industry Opportunities and Challenges Table 4. POC Diagnostics Industry Restraints Table 5. Global POC Diagnostics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global POC Diagnostics Revenue Share by Company (2021-2026) Table 7. Global POC Diagnostics Sales Volume by Company (K Units) & (2021-2026) Table 8. Global POC Diagnostics Sales Volume Share by Company (2021-2026) Table 9. Global POC Diagnostics Average Price (USD/Unit) of Company (2021-2026) Table 10. Global POC Diagnostics Company Ranking, (2024-2026) & (USD Million) Table 11. Global POC Diagnostics Key Company Manufacturing Base & Headquarters Table 12. Global POC Diagnostics Company, Product Type & Application Table 13. Global POC Diagnostics Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global POC Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Blood Glucose Testing Table 18. Significant Companies of Infectious Diseases Testing Table 19. Significant Companies of Cardiac Markers Testing Table 20. Significant Companies of Coagulation Testing Table 21. Significant Companies of Pregnancy and Fertility Testing Table 22. Significant Companies of Blood Gas or Electrolytes Testing Table 23. Significant Companies of Tumor Markers Testing Table 24. Significant Companies of Urinalysis Testing Table 25. Significant Companies of Cholesterol Testing Table 26. Significant Companies of Others Table 27. Global POC Diagnostics Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 28. Global POC Diagnostics Sales Volume by Type (2021-2026) & (K Units) Table 29. Global POC Diagnostics Sales Volume by Type (2027-2032) & (K Units) Table 30. Global POC Diagnostics Sales Volume Share by Type (2021-2026) Table 31. Global POC Diagnostics Sales Volume Share by Type (2027-2032) Table 32. Global POC Diagnostics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global POC Diagnostics Sales Value by Type (2021-2026) & (US$ Million) Table 34. Global POC Diagnostics Sales Value by Type (2027-2032) & (US$ Million) Table 35. Global POC Diagnostics Sales Value Share by Type (2021-2026) Table 36. Global POC Diagnostics Sales Value Share by Type (2027-2032) Table 37. Significant Companies of Clinics Table 38. Significant Companies of Hospitals Table 39. Significant Companies of Laboratory Table 40. Significant Companies of Others Table 41. Global POC Diagnostics Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global POC Diagnostics Sales Volume by Application (2021-2026) & (K Units) Table 43. Global POC Diagnostics Sales Volume by Application (2027-2032) & (K Units) Table 44. Global POC Diagnostics Sales Volume Share by Application (2021-2026) Table 45. Global POC Diagnostics Sales Volume Share by Application (2027-2032) Table 46. Global POC Diagnostics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global POC Diagnostics Sales Value by Application (2021-2026) & (US$ Million) Table 48. Global POC Diagnostics Sales Value by Application (2027-2032) & (US$ Million) Table 49. Global POC Diagnostics Sales Value Share by Application (2021-2026) Table 50. Global POC Diagnostics Sales Value Share by Application (2027-2032) Table 51. Global POC Diagnostics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 52. Global POC Diagnostics Sales by Region (2021-2026) & (K Units) Table 53. Global POC Diagnostics Sales Market Share by Region (2021-2026) Table 54. Global POC Diagnostics Sales by Region (2027-2032) & (K Units) Table 55. Global POC Diagnostics Sales Market Share by Region (2027-2032) Table 56. Global POC Diagnostics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global POC Diagnostics Sales Value by Region (2021-2026) & (US$ Million) Table 58. Global POC Diagnostics Sales Value Share by Region (2021-2026) Table 59. Global POC Diagnostics Sales Value by Region (2027-2032) & (US$ Million) Table 60. Global POC Diagnostics Sales Value Share by Region (2027-2032) Table 61. Global POC Diagnostics Market Average Price (USD/Unit) by Region (2021-2026) Table 62. Global POC Diagnostics Market Average Price (USD/Unit) by Region (2027-2032) Table 63. Global POC Diagnostics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 64. Global POC Diagnostics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global POC Diagnostics Sales by Country (2021-2026) & (K Units) Table 66. Global POC Diagnostics Sales Market Share by Country (2021-2026) Table 67. Global POC Diagnostics Sales by Country (2027-2032) & (K Units) Table 68. Global POC Diagnostics Sales Market Share by Country (2027-2032) Table 69. Global POC Diagnostics Sales Value by Country (2021-2026) & (US$ Million) Table 70. Global POC Diagnostics Sales Value Market Share by Country (2021-2026) Table 71. Global POC Diagnostics Sales Value by Country (2027-2032) & (US$ Million) Table 72. Global POC Diagnostics Sales Value Market Share by Country (2027-2032) Table 73. Alere Company Information Table 74. Alere Business Overview Table 75. Alere POC Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Alere POC Diagnostics Product Portfolio Table 77. Alere Recent Development Table 78. Roche Company Information Table 79. Roche Business Overview Table 80. Roche POC Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Roche POC Diagnostics Product Portfolio Table 82. Roche Recent Development Table 83. Abbott Laboratories Company Information Table 84. Abbott Laboratories Business Overview Table 85. Abbott Laboratories POC Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. Abbott Laboratories POC Diagnostics Product Portfolio Table 87. Abbott Laboratories Recent Development Table 88. Johnson & Johnson Company Information Table 89. Johnson & Johnson Business Overview Table 90. Johnson & Johnson POC Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Johnson & Johnson POC Diagnostics Product Portfolio Table 92. Johnson & Johnson Recent Development Table 93. Siemens Healthcare Company Information Table 94. Siemens Healthcare Business Overview Table 95. Siemens Healthcare POC Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. Siemens Healthcare POC Diagnostics Product Portfolio Table 97. Siemens Healthcare Recent Development Table 98. Danaher Company Information Table 99. Danaher Business Overview Table 100. Danaher POC Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 101. Danaher POC Diagnostics Product Portfolio Table 102. Danaher Recent Development Table 103. Bayer Healthcare Company Information Table 104. Bayer Healthcare Business Overview Table 105. Bayer Healthcare POC Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 106. Bayer Healthcare POC Diagnostics Product Portfolio Table 107. Bayer Healthcare Recent Development Table 108. Beckman Coulter Company Information Table 109. Beckman Coulter Business Overview Table 110. Beckman Coulter POC Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 111. Beckman Coulter POC Diagnostics Product Portfolio Table 112. Beckman Coulter Recent Development Table 113. Nipro Diagnostics Company Information Table 114. Nipro Diagnostics Business Overview Table 115. Nipro Diagnostics POC Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 116. Nipro Diagnostics POC Diagnostics Product Portfolio Table 117. Nipro Diagnostics Recent Development Table 118. Bio-Rad Laboratories Company Information Table 119. Bio-Rad Laboratories Business Overview Table 120. Bio-Rad Laboratories POC Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 121. Bio-Rad Laboratories POC Diagnostics Product Portfolio Table 122. Bio-Rad Laboratories Recent Development Table 123. Nova Biomedical Company Information Table 124. Nova Biomedical Business Overview Table 125. Nova Biomedical POC Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 126. Nova Biomedical POC Diagnostics Product Portfolio Table 127. Nova Biomedical Recent Development Table 128. BioMerieux Company Information Table 129. BioMerieux Business Overview Table 130. BioMerieux POC Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 131. BioMerieux POC Diagnostics Product Portfolio Table 132. BioMerieux Recent Development Table 133. Quidel Company Information Table 134. Quidel Business Overview Table 135. Quidel POC Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 136. Quidel POC Diagnostics Product Portfolio Table 137. Quidel Recent Development Table 138. Helena Laboratories Company Information Table 139. Helena Laboratories Business Overview Table 140. Helena Laboratories POC Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 141. Helena Laboratories POC Diagnostics Product Portfolio Table 142. Helena Laboratories Recent Development Table 143. OraSure Technologies Company Information Table 144. OraSure Technologies Business Overview Table 145. OraSure Technologies POC Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 146. OraSure Technologies POC Diagnostics Product Portfolio Table 147. OraSure Technologies Recent Development Table 148. Accriva Company Information Table 149. Accriva Business Overview Table 150. Accriva POC Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 151. Accriva POC Diagnostics Product Portfolio Table 152. Accriva Recent Development Table 153. Abaxis Company Information Table 154. Abaxis Business Overview Table 155. Abaxis POC Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 156. Abaxis POC Diagnostics Product Portfolio Table 157. Abaxis Recent Development Table 158. Chembio Diagnostics Company Information Table 159. Chembio Diagnostics Business Overview Table 160. Chembio Diagnostics POC Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 161. Chembio Diagnostics POC Diagnostics Product Portfolio Table 162. Chembio Diagnostics Recent Development Table 163. Trinity Biotech Company Information Table 164. Trinity Biotech Business Overview Table 165. Trinity Biotech POC Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 166. Trinity Biotech POC Diagnostics Product Portfolio Table 167. Trinity Biotech Recent Development Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. POC Diagnostics Distributors List Table 171. POC Diagnostics Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. POC Diagnostics Product Image Figure 2. Global POC Diagnostics Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global POC Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 4. Global POC Diagnostics Sales (2021-2032) & (K Units) Figure 5. Global POC Diagnostics Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global POC Diagnostics Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Blood Glucose Testing Image Figure 10. Infectious Diseases Testing Image Figure 11. Cardiac Markers Testing Image Figure 12. Coagulation Testing Image Figure 13. Pregnancy and Fertility Testing Image Figure 14. Blood Gas or Electrolytes Testing Image Figure 15. Tumor Markers Testing Image Figure 16. Urinalysis Testing Image Figure 17. Cholesterol Testing Image Figure 18. Others Image Figure 19. Global POC Diagnostics Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global POC Diagnostics Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global POC Diagnostics Sales Volume Share by Type (2021-2032) Figure 22. Global POC Diagnostics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global POC Diagnostics Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global POC Diagnostics Sales Value Share by Type (2021-2032) Figure 25. Clinics Image Figure 26. Hospitals Image Figure 27. Laboratory Image Figure 28. Others Image Figure 29. Global POC Diagnostics Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global POC Diagnostics Sales Volume Share 2021 VS 2025 VS 2032 Figure 31. Global POC Diagnostics Sales Volume Share by Application (2021-2032) Figure 32. Global POC Diagnostics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global POC Diagnostics Sales Value Share 2021 VS 2025 VS 2032 Figure 34. Global POC Diagnostics Sales Value Share by Application (2021-2032) Figure 35. Global POC Diagnostics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 36. Global POC Diagnostics Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 37. Global POC Diagnostics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 38. Global POC Diagnostics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 39. North America POC Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 40. North America POC Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Europe POC Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 42. Europe POC Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Asia-Pacific POC Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 44. Asia-Pacific POC Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 45. South America POC Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 46. South America POC Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 47. Middle East & Africa POC Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 48. Middle East & Africa POC Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 49. USA POC Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. USA POC Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. USA POC Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Canada POC Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Canada POC Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Canada POC Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Mexico POC Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Mexico POC Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Mexico POC Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Germany POC Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Germany POC Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Germany POC Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. France POC Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. France POC Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. France POC Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. U.K. POC Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. U.K. POC Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. U.K. POC Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Italy POC Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Italy POC Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Italy POC Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Spain POC Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Spain POC Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Spain POC Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Russia POC Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Russia POC Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Russia POC Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Netherlands POC Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Netherlands POC Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Netherlands POC Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Nordic Countries POC Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Nordic Countries POC Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Nordic Countries POC Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. China POC Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. China POC Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. China POC Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Japan POC Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Japan POC Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Japan POC Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. South Korea POC Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. South Korea POC Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. South Korea POC Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. India POC Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. India POC Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. India POC Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Australia POC Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Australia POC Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Australia POC Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Southeast Asia POC Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Southeast Asia POC Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Southeast Asia POC Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Brazil POC Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Brazil POC Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Brazil POC Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Argentina POC Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Argentina POC Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Argentina POC Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Chile POC Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Chile POC Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Chile POC Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Colombia POC Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Colombia POC Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Colombia POC Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Peru POC Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Peru POC Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Peru POC Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Saudi Arabia POC Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Saudi Arabia POC Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Saudi Arabia POC Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Israel POC Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Israel Arabia POC Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Israel Arabia POC Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. UAE POC Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. UAE POC Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. UAE POC Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Turkey POC Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Turkey POC Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Turkey POC Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Iran POC Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 128. Iran POC Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 129. Iran POC Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 130. Egypt POC Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 131. Egypt POC Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 132. Egypt POC Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 133. POC Diagnostics Value Chain Figure 134. Manufacturing Cost Structure Figure 135. POC Diagnostics Sales Mode & Process Figure 136. Direct Comparison with Distribution Share Figure 137. Distributors Profiles Figure 138. Years Considered Figure 139. Research Process Figure 140. Key Executives Interviewed

Scope & coverage.

Types
  • Blood Glucose Testing
  • Infectious Diseases Testing
  • Cardiac Markers Testing
  • Coagulation Testing
  • Pregnancy and Fertility Testing
  • Blood Gas or Electrolytes Testing
  • Tumor Markers Testing
  • Urinalysis Testing
  • Cholesterol Testing
  • Others
Applications
  • Clinics
  • Hospitals
  • Laboratory
  • Others
Companies covered
  • Alere
  • Roche
  • Abbott Laboratories
  • Johnson & Johnson
  • Siemens Healthcare
  • Danaher
  • Bayer Healthcare
  • Beckman Coulter
  • Nipro Diagnostics
  • Bio-Rad Laboratories
  • Nova Biomedical
  • BioMerieux
  • Quidel
  • Helena Laboratories
  • OraSure Technologies
  • Accriva
  • Abaxis
  • Chembio Diagnostics
  • Trinity Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global POC Diagnostics Sales Value (2021-2032)
  4. 1.2.2 Global POC Diagnostics Sales Volume (2021-2032)
  5. 1.2.3 Global POC Diagnostics Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 POC Diagnostics Market Dynamics
  1. 2.1 POC Diagnostics Industry Trends
  2. 2.2 POC Diagnostics Industry Drivers
  3. 2.3 POC Diagnostics Industry Opportunities and Challenges
  4. 2.4 POC Diagnostics Industry Restraints
3 POC Diagnostics Market by Company
  1. 3.1 Global POC Diagnostics Company Revenue Ranking in 2025
  2. 3.2 Global POC Diagnostics Revenue by Company (2021-2026)
  3. 3.3 Global POC Diagnostics Sales Volume by Company (2021-2026)
  4. 3.4 Global POC Diagnostics Average Price by Company (2021-2026)
  5. 3.5 Global POC Diagnostics Company Ranking (2024-2026)
  6. 3.6 Global POC Diagnostics Company Manufacturing Base and Headquarters
  7. 3.7 Global POC Diagnostics Company Product Type and Application
  8. 3.8 Global POC Diagnostics Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global POC Diagnostics Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 POC Diagnostics Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 POC Diagnostics Market by Type
  1. 4.1 POC Diagnostics Type Introduction
  2. 4.1.1 Blood Glucose Testing
  3. 4.1.2 Infectious Diseases Testing
  4. 4.1.3 Cardiac Markers Testing
  5. 4.1.4 Coagulation Testing
  6. 4.1.5 Pregnancy and Fertility Testing
  7. 4.1.6 Blood Gas or Electrolytes Testing
  8. 4.1.7 Tumor Markers Testing
  9. 4.1.8 Urinalysis Testing
  10. 4.1.9 Cholesterol Testing
  11. 4.1.10 Others
  12. 4.2 Global POC Diagnostics Sales Volume by Type
  13. 4.2.1 Global POC Diagnostics Sales Volume by Type (2021 VS 2025 VS 2032)
  14. 4.2.2 Global POC Diagnostics Sales Volume by Type (2021-2032)
  15. 4.2.3 Global POC Diagnostics Sales Volume Share by Type (2021-2032)
  16. 4.3 Global POC Diagnostics Sales Value by Type
  17. 4.3.1 Global POC Diagnostics Sales Value by Type (2021 VS 2025 VS 2032)
  18. 4.3.2 Global POC Diagnostics Sales Value by Type (2021-2032)
  19. 4.3.3 Global POC Diagnostics Sales Value Share by Type (2021-2032)
5 POC Diagnostics Market by Application
  1. 5.1 POC Diagnostics Application Introduction
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Laboratory
  5. 5.1.4 Others
  6. 5.2 Global POC Diagnostics Sales Volume by Application
  7. 5.2.1 Global POC Diagnostics Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global POC Diagnostics Sales Volume by Application (2021-2032)
  9. 5.2.3 Global POC Diagnostics Sales Volume Share by Application (2021-2032)
  10. 5.3 Global POC Diagnostics Sales Value by Application
  11. 5.3.1 Global POC Diagnostics Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global POC Diagnostics Sales Value by Application (2021-2032)
  13. 5.3.3 Global POC Diagnostics Sales Value Share by Application (2021-2032)
6 POC Diagnostics Regional Sales and Value Analysis
  1. 6.1 Global POC Diagnostics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global POC Diagnostics Sales by Region (2021-2032)
  3. 6.2.1 Global POC Diagnostics Sales by Region: 2021-2026
  4. 6.2.2 Global POC Diagnostics Sales by Region (2027-2032)
  5. 6.3 Global POC Diagnostics Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global POC Diagnostics Sales Value by Region (2021-2032)
  7. 6.4.1 Global POC Diagnostics Sales Value by Region: 2021-2026
  8. 6.4.2 Global POC Diagnostics Sales Value by Region (2027-2032)
  9. 6.5 Global POC Diagnostics Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America POC Diagnostics Sales Value (2021-2032)
  12. 6.6.2 North America POC Diagnostics Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe POC Diagnostics Sales Value (2021-2032)
  15. 6.7.2 Europe POC Diagnostics Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific POC Diagnostics Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific POC Diagnostics Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America POC Diagnostics Sales Value (2021-2032)
  21. 6.9.2 South America POC Diagnostics Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa POC Diagnostics Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa POC Diagnostics Sales Value Share by Country, 2025 VS 2032
7 POC Diagnostics Country-level Sales and Value Analysis
  1. 7.1 Global POC Diagnostics Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global POC Diagnostics Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global POC Diagnostics Sales by Country (2021-2032)
  4. 7.3.1 Global POC Diagnostics Sales by Country (2021-2026)
  5. 7.3.2 Global POC Diagnostics Sales by Country (2027-2032)
  6. 7.4 Global POC Diagnostics Sales Value by Country (2021-2032)
  7. 7.4.1 Global POC Diagnostics Sales Value by Country (2021-2026)
  8. 7.4.2 Global POC Diagnostics Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA POC Diagnostics Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA POC Diagnostics Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA POC Diagnostics Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada POC Diagnostics Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada POC Diagnostics Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada POC Diagnostics Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico POC Diagnostics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico POC Diagnostics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico POC Diagnostics Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany POC Diagnostics Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany POC Diagnostics Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany POC Diagnostics Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France POC Diagnostics Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France POC Diagnostics Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France POC Diagnostics Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. POC Diagnostics Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. POC Diagnostics Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. POC Diagnostics Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy POC Diagnostics Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy POC Diagnostics Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy POC Diagnostics Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain POC Diagnostics Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain POC Diagnostics Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain POC Diagnostics Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia POC Diagnostics Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia POC Diagnostics Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia POC Diagnostics Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands POC Diagnostics Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands POC Diagnostics Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands POC Diagnostics Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries POC Diagnostics Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries POC Diagnostics Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries POC Diagnostics Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China POC Diagnostics Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China POC Diagnostics Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China POC Diagnostics Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan POC Diagnostics Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan POC Diagnostics Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan POC Diagnostics Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea POC Diagnostics Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea POC Diagnostics Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea POC Diagnostics Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India POC Diagnostics Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India POC Diagnostics Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India POC Diagnostics Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia POC Diagnostics Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia POC Diagnostics Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia POC Diagnostics Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia POC Diagnostics Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia POC Diagnostics Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia POC Diagnostics Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil POC Diagnostics Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil POC Diagnostics Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil POC Diagnostics Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina POC Diagnostics Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina POC Diagnostics Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina POC Diagnostics Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile POC Diagnostics Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile POC Diagnostics Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile POC Diagnostics Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia POC Diagnostics Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia POC Diagnostics Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia POC Diagnostics Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru POC Diagnostics Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru POC Diagnostics Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru POC Diagnostics Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia POC Diagnostics Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia POC Diagnostics Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia POC Diagnostics Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel POC Diagnostics Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel POC Diagnostics Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel POC Diagnostics Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE POC Diagnostics Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE POC Diagnostics Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE POC Diagnostics Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey POC Diagnostics Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey POC Diagnostics Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey POC Diagnostics Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran POC Diagnostics Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran POC Diagnostics Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran POC Diagnostics Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt POC Diagnostics Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt POC Diagnostics Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt POC Diagnostics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Alere
  2. 8.1.1 Alere Company Information
  3. 8.1.2 Alere Business Overview
  4. 8.1.3 Alere POC Diagnostics Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Alere POC Diagnostics Product Portfolio
  6. 8.1.5 Alere Recent Developments
  7. 8.2 Roche
  8. 8.2.1 Roche Company Information
  9. 8.2.2 Roche Business Overview
  10. 8.2.3 Roche POC Diagnostics Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Roche POC Diagnostics Product Portfolio
  12. 8.2.5 Roche Recent Developments
  13. 8.3 Abbott Laboratories
  14. 8.3.1 Abbott Laboratories Company Information
  15. 8.3.2 Abbott Laboratories Business Overview
  16. 8.3.3 Abbott Laboratories POC Diagnostics Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Abbott Laboratories POC Diagnostics Product Portfolio
  18. 8.3.5 Abbott Laboratories Recent Developments
  19. 8.4 Johnson & Johnson
  20. 8.4.1 Johnson & Johnson Company Information
  21. 8.4.2 Johnson & Johnson Business Overview
  22. 8.4.3 Johnson & Johnson POC Diagnostics Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Johnson & Johnson POC Diagnostics Product Portfolio
  24. 8.4.5 Johnson & Johnson Recent Developments
  25. 8.5 Siemens Healthcare
  26. 8.5.1 Siemens Healthcare Company Information
  27. 8.5.2 Siemens Healthcare Business Overview
  28. 8.5.3 Siemens Healthcare POC Diagnostics Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Siemens Healthcare POC Diagnostics Product Portfolio
  30. 8.5.5 Siemens Healthcare Recent Developments
  31. 8.6 Danaher
  32. 8.6.1 Danaher Company Information
  33. 8.6.2 Danaher Business Overview
  34. 8.6.3 Danaher POC Diagnostics Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Danaher POC Diagnostics Product Portfolio
  36. 8.6.5 Danaher Recent Developments
  37. 8.7 Bayer Healthcare
  38. 8.7.1 Bayer Healthcare Company Information
  39. 8.7.2 Bayer Healthcare Business Overview
  40. 8.7.3 Bayer Healthcare POC Diagnostics Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Bayer Healthcare POC Diagnostics Product Portfolio
  42. 8.7.5 Bayer Healthcare Recent Developments
  43. 8.8 Beckman Coulter
  44. 8.8.1 Beckman Coulter Company Information
  45. 8.8.2 Beckman Coulter Business Overview
  46. 8.8.3 Beckman Coulter POC Diagnostics Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Beckman Coulter POC Diagnostics Product Portfolio
  48. 8.8.5 Beckman Coulter Recent Developments
  49. 8.9 Nipro Diagnostics
  50. 8.9.1 Nipro Diagnostics Company Information
  51. 8.9.2 Nipro Diagnostics Business Overview
  52. 8.9.3 Nipro Diagnostics POC Diagnostics Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Nipro Diagnostics POC Diagnostics Product Portfolio
  54. 8.9.5 Nipro Diagnostics Recent Developments
  55. 8.10 Bio-Rad Laboratories
  56. 8.10.1 Bio-Rad Laboratories Company Information
  57. 8.10.2 Bio-Rad Laboratories Business Overview
  58. 8.10.3 Bio-Rad Laboratories POC Diagnostics Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Bio-Rad Laboratories POC Diagnostics Product Portfolio
  60. 8.10.5 Bio-Rad Laboratories Recent Developments
  61. 8.11 Nova Biomedical
  62. 8.11.1 Nova Biomedical Company Information
  63. 8.11.2 Nova Biomedical Business Overview
  64. 8.11.3 Nova Biomedical POC Diagnostics Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Nova Biomedical POC Diagnostics Product Portfolio
  66. 8.11.5 Nova Biomedical Recent Developments
  67. 8.12 BioMerieux
  68. 8.12.1 BioMerieux Company Information
  69. 8.12.2 BioMerieux Business Overview
  70. 8.12.3 BioMerieux POC Diagnostics Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 BioMerieux POC Diagnostics Product Portfolio
  72. 8.12.5 BioMerieux Recent Developments
  73. 8.13 Quidel
  74. 8.13.1 Quidel Company Information
  75. 8.13.2 Quidel Business Overview
  76. 8.13.3 Quidel POC Diagnostics Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Quidel POC Diagnostics Product Portfolio
  78. 8.13.5 Quidel Recent Developments
  79. 8.14 Helena Laboratories
  80. 8.14.1 Helena Laboratories Company Information
  81. 8.14.2 Helena Laboratories Business Overview
  82. 8.14.3 Helena Laboratories POC Diagnostics Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Helena Laboratories POC Diagnostics Product Portfolio
  84. 8.14.5 Helena Laboratories Recent Developments
  85. 8.15 OraSure Technologies
  86. 8.15.1 OraSure Technologies Company Information
  87. 8.15.2 OraSure Technologies Business Overview
  88. 8.15.3 OraSure Technologies POC Diagnostics Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 OraSure Technologies POC Diagnostics Product Portfolio
  90. 8.15.5 OraSure Technologies Recent Developments
  91. 8.16 Accriva
  92. 8.16.1 Accriva Company Information
  93. 8.16.2 Accriva Business Overview
  94. 8.16.3 Accriva POC Diagnostics Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Accriva POC Diagnostics Product Portfolio
  96. 8.16.5 Accriva Recent Developments
  97. 8.17 Abaxis
  98. 8.17.1 Abaxis Company Information
  99. 8.17.2 Abaxis Business Overview
  100. 8.17.3 Abaxis POC Diagnostics Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Abaxis POC Diagnostics Product Portfolio
  102. 8.17.5 Abaxis Recent Developments
  103. 8.18 Chembio Diagnostics
  104. 8.18.1 Chembio Diagnostics Company Information
  105. 8.18.2 Chembio Diagnostics Business Overview
  106. 8.18.3 Chembio Diagnostics POC Diagnostics Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Chembio Diagnostics POC Diagnostics Product Portfolio
  108. 8.18.5 Chembio Diagnostics Recent Developments
  109. 8.19 Trinity Biotech
  110. 8.19.1 Trinity Biotech Company Information
  111. 8.19.2 Trinity Biotech Business Overview
  112. 8.19.3 Trinity Biotech POC Diagnostics Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Trinity Biotech POC Diagnostics Product Portfolio
  114. 8.19.5 Trinity Biotech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 POC Diagnostics Value Chain Analysis
  2. 9.1.1 POC Diagnostics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 POC Diagnostics Sales Mode & Process
  6. 9.2 POC Diagnostics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 POC Diagnostics Distributors
  9. 9.2.3 POC Diagnostics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst